• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bioventus Inc. - Class A Common Stock (NQ:BVS)

6.115 -0.405 (-6.21%)
Streaming Delayed Price Updated: 3:06 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 333,175
Open 6.450
Bid (Size) 6.100 (25)
Ask (Size) 6.130 (9)
Prev. Close 6.520
Today's Range 6.030 - 6.500
52wk Range 6.020 - 14.38
Shares Outstanding 10
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products
July 30, 2025
From Bioventus, Inc.
Via GlobeNewswire
Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025
July 29, 2025
From Bioventus, Inc.
Via GlobeNewswire

Performance

YTD
-42.5%
-42.5%
1 Month
-12.3%
-12.3%
3 Month
-15.8%
-15.8%
6 Month
-42.6%
-42.6%
1 Year
-12.8%
-12.8%

More News

Read More
Bioventus Reports First Quarter Financial Results
May 06, 2025
From Bioventus, Inc.
Via GlobeNewswire
Earnings Scheduled For May 6, 2025
May 06, 2025
Via Benzinga
Examining the Future: Bioventus's Earnings Outlook
May 05, 2025
Via Benzinga
Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
April 28, 2025
From Bioventus, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 07, 2025
Via Benzinga
Gapping stocks in Tuesday's session
March 11, 2025
Via Chartmill
Medical Device Firm Bioventus Stock Jumps On Upbeat 2025 Outlook, Cuts Debt By $48 Million
March 11, 2025
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
March 11, 2025
Via Chartmill
Korn Ferry Posts Better-Than-Expected Earnings, Joins Bioventus, Endeavour Silver, Vail Resorts And Other Big Stocks Moving Higher On Tuesday
March 11, 2025
Via Benzinga
Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results
March 11, 2025
From Bioventus, Inc.
Via GlobeNewswire
Earnings Scheduled For March 11, 2025
March 11, 2025
Via Benzinga
Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025
February 28, 2025
From Bioventus, Inc.
Via GlobeNewswire
Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 07, 2025
From Bioventus, Inc.
Via GlobeNewswire
Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
January 02, 2025
From Bioventus, Inc.
Via GlobeNewswire
Dow Jumps 400 Points; Yum! Brands Posts Downbeat Earnings
November 05, 2024
Via Benzinga
Topics Stocks
S&P 500 Gains 1%; Vimeo Shares Spike Higher
November 05, 2024
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 05, 2024
Via Benzinga
Nasdaq Gains Over 100 Points; US Trade Deficit Widens In September
November 05, 2024
Via Benzinga
Bioventus Reports Third Quarter Financial Results
November 05, 2024
From Bioventus, Inc.
Via GlobeNewswire
Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
October 29, 2024
From Bioventus, Inc.
Via GlobeNewswire
Solventum Stock Earns 81 RS Rating
October 15, 2024
Via Investor's Business Daily
Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
October 01, 2024
From Bioventus, Inc.
Via GlobeNewswire
Executives Buying W. P. Carey And 2 Other Stocks
August 21, 2024
Via Benzinga

Frequently Asked Questions

Is Bioventus Inc. - Class A Common Stock publicly traded?
Yes, Bioventus Inc. - Class A Common Stock is publicly traded.
What exchange does Bioventus Inc. - Class A Common Stock trade on?
Bioventus Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Bioventus Inc. - Class A Common Stock?
The ticker symbol for Bioventus Inc. - Class A Common Stock is BVS on the Nasdaq Stock Market
What is the current price of Bioventus Inc. - Class A Common Stock?
The current price of Bioventus Inc. - Class A Common Stock is 6.115
When was Bioventus Inc. - Class A Common Stock last traded?
The last trade of Bioventus Inc. - Class A Common Stock was at 08/01/25 03:06 PM ET
What is the market capitalization of Bioventus Inc. - Class A Common Stock?
The market capitalization of Bioventus Inc. - Class A Common Stock is 61.15
How many shares of Bioventus Inc. - Class A Common Stock are outstanding?
Bioventus Inc. - Class A Common Stock has 61 shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap